Vascular-Targeted Photodynamic Therapy Using WST11 in Patients With Localized Prostate Cancer.

Trial Profile

Vascular-Targeted Photodynamic Therapy Using WST11 in Patients With Localized Prostate Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Oct 2015

At a glance

  • Drugs Padeliporfin (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Sponsors Steba Biotech
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 14 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Jul 2012 Planned end date changed from 1 Apr 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top